Dihydrotanshinone I (DI), a naturally occurring compound extracted from Salvia miltiorrhiza Bunge, has been reported to have cytotoxicity to a variety of tumor cells. In this study, we investigated its anti-angiogenic capacity in human umbilical vein endothelial cells. DI induced a potent cytotoxicity to human umbilical vein endothelial cells, with an IC 50 value of approximately 1.28 μg/ml. At 0.25−1 μg/ml, DI dose-dependently suppressed human umbilical vein endothelial cell migration, invasion, and tube formation detected by wound healing, Transwell invasion and Matrigel tube formation assays, respectively. Moreover, DI showed significant in vivo anti-angiogenic activity in chick embryo chorioallantoic membrane assay. DI induced a 61.1% inhibitory rate of microvessel density at 0.2 μg/egg. Taken together, our results showed that DI could inhibit angiogenesis through suppressing endothelial cell proliferation, migration, invasion and tube formation, indicating that DI has a potential to be developed as a novel anti-angiogenic agent.
Angiogenesis is a process of new blood vessel formation by endothelial cells that plays a critical role in normal physiology, such as development and wound healing [1] . At the pathological level, angiogenesis is regulated by numerous pro-angiogenic factors leading to the induction of several diseases such as spreading of tumor, diabetic retinopathy, and rheumatoid arthritis [2] . Most primary solid tumors are dependent on angiogenesis for survival, growth, invasion, and metastasis. Therefore, targeting the angiogenesis process has become one of the important strategies in treating tumors [3] . In the angiogenesis process, vascular endothelial cells are activated to migrate out from the parental vessels, invade through the matrix, proliferate, and get together to format capillary tubes. Each step is tightly controlled by pro-and anti-angiogenic factors [4] . In tumor tissues, vascular endothelial growth factor (VEGF), basic fibroblast growth factor, and other proangiogenic factors are usually overexpressed [5] , whereas anti-angiogenic factors such as interleukin-12 (IL-12) and γ-interferon have few functions [6] . Thus, the antiangiogenic therapy strategy is to suppress the functions of pro-angiogenesis factors and/or promote the functions of anti-angiogenesis factors. Currently, there are a variety of angiogenesis inhibitors being used in clinical trials [6, 7] , many of which are natural products. Drug development from natural products has become a rapidly emerging and highly promising strategy to identify novel anti-angiogenic and anticancer agents.
Dihydrotanshinone I (DI) is a tanshinone extracted from a well-known traditional Chinese medicinal plant, Salvia miltiorrhiza Bunge. The dry root of this plant, called Danshen, has been widely used in China to treat haematological abnormalities, heart disease, hepatitis, hemorrhage, menstrual abnormalities, and collageninduced platelet aggregation [8, 9] . DI was reported to possess the function of cytotoxicity in vitro [10] and showed inhibitory effects on mast cell degranulation [11] , lipopolysaccharide-induced nitric oxide generation [12] , osteoclast differentiation [13] , and production of IL-12 and γ-interferon in immune cells [14] . However, its antiangiogenic capacity has not been well studied. Considering IL-12 and nitric oxide both play important roles in mediating angiogenesis [15, 16] , we hypothesized that DI might have an anti-angiogenic action.
In this study, we used different assays to identify and characterize whether DI could induce inhibitory effects 
Materials and Methods
Drugs and reagents DI was bought from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). It was dissolved with ethanol for the stock concentration of 5 mg/ml, and stored at −20 ºC. The stock solution was further diluted immediately before use. Dimethyl thiazolyl-2,5-diphenyltetrazolium bromide (MTT) was purchased from Sigma (St. Louis, USA). Dulbcco's modified Eagle's medium (DMEM), Medium 199, fetal bovine serum, and bovine calf serum were obtained from Gibco (Rockville, USA).
Isolation of human umbilical vein endothelial cells (HUVECs) and cell cultures
HUVECs were isolated from fresh human umbilical veins by established methods as described previously [17] . Briefly, endothelial cells were harvested from human umbilical veins by adding 0.1% collagenase (Gibco) for 30 min. The cells were grown to confluence in Medium 199 supplemented with 20% heat-inactivated fetal bovine serum, 100 mM HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM glutamine, 5 ng/ml acidic fibroblast growth factor (aFGF) (Sigma), and 5 U/ml heparin. Cells were assessed for endothelial cell phenotype by morphology, the typical monolayer cobblestone growth pattern, and the expression of von Willebrand factor antigen. Cells between passages 1 and 2 and cell populations with more than 95% purity were used in all experiments.
The hepatocellular carcinoma SMMC-7721 cell line was obtained from the Committee of Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Cells were maintained in DMEM supplemented with 10% bovine calf serum, incubated in a humidified atmosphere of 5% CO 2 at 37 ºC, and subcultured every 2 d.
MTT assay
Cells were seeded in 96-well tissue culture plates (4000 cells/well), incubated for 24 h, then treated with various concentrations of DI for another 24 h. Then 20 μl MTT was added to each well (final concentration of 0.5 mg/ml) for another 4 h incubation. The medium was pipetted out from each well, 200 μl dimethyl sulfoxide was added and the optical density was read at 570 nm. The IC 50 values were calculated and defined as the concentration of drug causing 50% inhibition in absorbance compared with control cells [18] .
Wound healing assay
The wound healing assay was carried out according to previous studies [19] . Briefly, HUVECs were seeded on 24-well tissue culture plates. When the cells reached 90% confluence, they were wounded with a tip from the center of each well and marked at the injury line. After wounding, the cultures were washed with serum-free medium and further incubated with different concentrations of DI for 24 h. Then cells in each well were stained with WrightGiemsa, and photographed under an inverted microscope. The total migrated cells in each group were quantified by counting the number of cells that moved beyond the reference lines in five views.
Cell invasion assay
Cell invasion assay was carried out using Transwell chambers (Corning, New York, USA) with an 8 μm pore polycarbonate filter insert (Corning) according to a previous report [20] . Briefly, the upper side of every insert was coated with 10 μl Matrigel (3 mg/ml; Becton Dickinson, Mountain View, USA). HUVECs (3×10 4 cells/well) were seeded in the upper inserts, and SMMC-7721 cells were seeded in the lower chamber 24 h beforehand. After 6 h of incubation, the medium in the inserts was pipetted out and 150 μl medium with different concentrations of DI was added. Chambers were incubated for 24 h. Cells on the lower surface of the filters were fixed and stained with Wright-Giemsa and sealed on slides. Stained filters were photographed under a microscope. Invasiveness was determined by counting the cell number. Five visual fields were chosen randomly for each filter. The average number of the invaded cells in the five fields was taken as the mean of cell invasion numbers of the group.
In vitro tube formation assay
Unpolymerized Matrigel (17 mg/ml) was placed in a 96-well plate (0.32 cm 2 /well) at 50 μl/well and polymerized for 1 h at 37 ºC. HUVECs (2×10 4 cells/well) in 200 μl medium, as well as in the presence or absence of DI (0.25, 0.5, and 1 μg/ml) were layered onto the Matrigel surface. After 24 h of incubation, cell growth and 3-D organization were observed under a microscope [21] .
Chick embryo chorioallantoic membrane (CAM) assay
The modified CAM assay was used to evaluate the inhibitory effects on angiogenesis in vivo on a chicken embryo model according to a previous report [22] .
Fertilized chick eggs were incubated at 37 ºC and with 60% humidity for 6 d. Then a square window was opened on the egg's shell, exposing the CAM and ensuring that the yolk sac membrane remained intact and the embryo was viable. A methylcellulose membrane loaded with various concentrations of DI was placed in areas between vessels of the 6-d-old egg but never onto any large vessels. Then the window was covered with tape. After another 48 h of incubation, the CAMs were fixed in situ, excised from the eggs, placed on slides, and left to air dry. Pictures were taken through a stereoscope equipped with a digital camera. Local vessel density was measured and the inhibitory effects on CAM angiogenesis were evaluated. Assays were repeated three times and each experiment group included 10 eggs.
Statistical analysis
All of the experiments were carried out at least in triplicate. The results are expressed as mean±SD. The statistical differences between means were evaluated using Student's t-test. Differences between two groups were determined using a P-value. A value of P<0.05 was regarded as being statistically significant.
Results

DI induced cytotoxicity in HUVECs and SMMC-7721 cells
Cells were treated with increasing concentrations of DI for 24 h, then cell viability was determined by MTT assay. The cell viability was shown as the DI dose-dependent reduction in both HUVECs and SMMC-7721 cells (Fig. 1) . The IC 50 values were 1.28 and 5.02 μg/ml for HUVECs and SMMC-7721 cells, respectively. We set the working concentrations of DI as 0.25, 0.5, and 1 μg/ml for the following experiments.
DI inhibited HUVEC migration
The wound healing migration assay is an established and widely-used procedure that allows an examination of cell migration in response to an artificial wound produced on a cell monolayer. DI showed a dose-dependent inhibitory effect on the wound healing ability of HUVECs (Fig. 2) . The control group produced a distinguished cell migration in the wound area 24 h after wounding, whereas DItreated groups (0.25, 0.5 and 1 μg/ml) showed dosedependent inhibitory effects on wound healing under the same conditions [ Fig. 2(A)] . The mean migratory cell number in five fields in the control group was 504±23, but in experimental groups treated with DI at 0.25, 0.5, or 1 μg/ml, the cell numbers were 349±42, 295±22, and 172±28, respectively, with inhibitory rates of 30.75% (P<0.05), 41.81% (P<0.05), and 65.87% (P<0.01), respectively. These results indicated that sub-cytotoxicity of DI inhibited the motility of HUVECs.
DI suppresses HUVEC invasion in a dose-dependent way
The invasion of endothelial cells is also one of the critical features in the formation of new blood vessels and in the repair of injured vessels. We investigated the invasion ability of HUVECs through Transwell inserts. Results showed that the average number of invaded cells in the control was 159.33±5.68, and the numbers were 135.33±4.04, 82.00±10.54, and 41.00±3.61 in 0.25, 0.5, and 1 μg/ml groups, respectively, with inhibitory rates of 15.06% (P<0.05), 48.53% (P<0.05), and 74.27% (P<0.01), respectively. In agreement with the results of the wound healing assay, DI at all three tested doses significantly inhibited HUVEC invasion (P<0.05 or P<0.01). The inhibitory effect was dose-dependent (Fig. 3) .
DI inhibited in vitro tube formation on Matrigel
The production of tubular structures is another important step in angiogenesis. We therefore investigated the effects of DI on HUVEC tube formation. As shown in Fig. 4 , HUVECs plated on Matrigel and incubated with control medium aligned to form lumen-like structures and anastomotic tubes with multicentric junctions [Fig. 4(A) ]. When HUVECs were treated with various concentrations of DI for 24 h, the cells formed fewer tubes, as well as fewer and weaker anastomoses, in a dose-dependent manner [ Fig. 4(B−D) ].
DI reduced in vivo angiogenesis in CAM model
CAM assay is a widely-used model to determine angiogenesis in vivo. The average vessel numbers under the methylcellulose membrane in the four groups (vehicle, ethanol, 0.1 μg DI/egg, and 0.2 μg DI/egg) were 69.25±29.64, 70.00±36.23, 31.17±11.94, and 27.20±9.09, respectively (Fig. 5) . The vessel density between the vehicle and ethanol groups had no significant difference (P>0.05). Experimental groups both represented distinguished differences from the vehicle and ethanol groups (P<0.05). This result suggested that DI had an inhibitory effect on in vivo angiogenesis in CAM model.
Discussion
Angiogenesis plays a critical role in tumor invasion and metastasis [23] . In the initial process of tumor invasion, angiogenesis is activated by the pro-angiogenesis factors produced by environmental cells. Notably, VEGF plays a key role in the whole angiogenesis processes. VEGF can be expressed and secreted by various solid tumor cells mediated by hypoxia inducible factor 1 (HIF-1) [4] . With a high invasion and metastasis capacity, human hepatocellular cells secrete a certain level of VEGF and express VEGF receptors [5] . Based on this and other studies, VEGF monoclonal antibodies have been used in the clinic to treat metastasis cancers [24] . Other angiogenesis inhibitors suppress angiogenesis by blocking signal transduction induced by VEGF [25] .
In the HUVEC invasion assay in this study, we put SMMC-7721 cells on the lower chamber of the Transwell, and found DI treated groups significantly suppressed the invasion of HUVECs to the lower chamber (Fig. 3) , suggesting DI might block the signal transduction of VEGF produced by SMMC-7721 cells. In addition, DI directly induced cytotoxicity in HUVECs, with the IC 50 3.92-fold less than that in SMMC-7721 cells (Fig. 1) . This result indicates that, in treating solid tumors like hepatocellular carcinoma, DI might preferentially target vascular endothelial cells to tumor cells.
The anti-angiogenesis capacity of DI might be underlined by its chemical structure. The anti-angiogenesis capacity of cryptotanshinone was determined by the double bond at the C-15 position of the dihydrofuran ring [26] . DI is another tanshinone with such a key structure [27] . In our previous study, we found both cryptotanshinone and DI could inhibit HIF-1 activity by HIF-1 receptor using the screening method (data not shown), and this finding was verified by Dat et al [28] . Previous studies have shown that cryptotanshinone could inhibit vascular endothelia cell invasion, tube formation in vitro, and CAM angiogenesis in vivo [22, 29] . In this study, we illustrated that DI (0.25−1 μg/ml) possessed the capacity to suppress HUVEC migration (Fig. 2), invasion (Fig. 3) , and tube formation (Fig. 4) . The mechanism might be that DI blocked the signal transduction of the effects of some growth factors, like VEGF, produced by tumor cells, but this remains to be further investigated. Also, DI could suppress microvessel density in vivo in the CAM model 
